Global Breast Cancer Therapeutics Market 2019-2023

The breast cancer therapeutics market size will grow by close to USD 8.1 billion during 2019-2023. This report offers an analysis of the market based on product (targeted therapy, hormonal therapy, and chemotherapy). The breast cancer therapeutics market research report further presents in-depth insights on the growth prospects of the market across geographic regions- the Americas, APAC, and EMEA. The report analyzes the market’s competitive landscape and offers information on several breast cancer therapeutic suppliers including AstraZeneca, Eli Lilly, F. Hoffmann-La Roche, Novartis, and Pfizer.

Below are some of the key findings from the breast cancer therapeutics industry analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE Sample now!

Global breast cancer therapeutics industry overview

Breast cancer therapeutics industry growth is expected to accelerate over the next five years, driven by the rising prevalence of breast cancer. Although early diagnosis is used as a preventive approach, the risk of breast cancer remains unchanged. According to the CDC, around 237,000 and 2,100 cases of breast cancer are diagnosed in women and men, respectively, every year in the US. The incidence and mortality of cancer differ in countries as it has different risk factors that increase the risk of breast cancer in predisposed individuals. Some of the risk factors for breast cancer include BRCA1 or BRCA2 mutations, dense breast density, abnormal breast biopsy, early menarche or late menopause, HRT, post-menopausal obesity, alcohol consumption, smoking, and lifestyle. Other factors such as socioeconomic status, education level, and access to care also influence mortality after the disease is diagnosed. These factors attribute to the rising prevalence of breast cancer at an exponential rate in the world, which is forecasted to boost the growth of the global breast cancer therapeutics market over the next five years. The robust pipeline and new drug approvals will drive the breast cancer therapeutics market to grow at a CAGR of close to 8% during the forecast period.

Top breast cancer therapeutic suppliers covered in this market research report

The breast cancer therapeutics market is fragmented with the existence of many breast cancer therapeutic manufacturers who offer products such as targeted therapy, hormonal therapy, and chemotherapy. Many established breast cancer therapeutic suppliers are vying for their share of the global breast cancer therapeutics market, and the new players must differentiate themselves to gain vital traction over their peers. By offering a complete analysis of the market’s competitive landscape and with information on the products provided by the suppliers, this breast cancer therapeutics industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies for improving their share in the market.

The report offers a complete analysis of various breast cancer therapeutic suppliers including:

• AstraZeneca
• Eli Lilly
• F. Hoffmann-La Roche
• Novartis
• Pfizer

Breast cancer therapeutics market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the breast cancer therapeutic suppliers, the Americas will contribute to the highest growth of this market throughout the forecast period. The rising prevalence of breast cancer, new drug approvals, and reimbursement schemes are some of the primary reasons for the high growth of the breast cancer therapeutics market in this region.

Breast cancer therapeutics market segmentation based on product type

• Targeted therapy
• Hormonal therapy
• Chemotherapy

The targeted therapy product segment will account for the largest share in the breast cancer therapeutics market. Additionally, the report also provides an accurate prediction of the contribution of the various product types to the growth of the breast cancer therapeutics market size.

Key highlights of the global breast cancer therapeutics market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the breast cancer therapeutics market during the next five years
• Precise estimation of the global breast cancer therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the breast cancer therapeutics industry across various geographies such as the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive information about factors that will challenge the growth of breast cancer therapeutic companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch